Abstract
Cellular response to TBI is a mixture of excitotoxicity, neuroinflammation, and cell death. Biomarkers that can track these lesions and inflammatory processes are being explored for their potential to provide objective measures in the evaluation of TBI, from prehospital care to rehabilitation. By understanding the pathways involved, we could be able to improve diagnostic accuracy, guide management, and prevent long-term disability. We listed some of the recent advances in this translational, intriguing, fast-growing field. Although the knowledge gaps are still significant, some markers are showing promising results and could be helping patients in the near future.
Similar content being viewed by others
References
Agoston DV, Shutes-David A, Peskind ER (2017) Biofluid biomarkers of traumatic brain injury. Brain Inj 31:1195–1203. https://doi.org/10.1080/02699052.2017.1357836
Akgun B, Erol FS, Yildirim H, Ilhan N, Kaplan M (2013) The correlation of serum NT-proBNP levels of hemorrhagic and ischemic lesions detected with diffusion MRI in head traumas. Turk Neurosurg 23:336–343. https://doi.org/10.5137/1019-5149.JTN.6982-12.1
Anderson T, Hwang J, Munar M, Papa L, Hinson HE, Vaughan A, Rowell S (2020) Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury. J Trauma Acute Care Surg Publish Ah 89:80–86. https://doi.org/10.1097/TA.0000000000002706
Di Battista AP, Rizoli SB, Lejnieks B, Min A, Shiu MY, Peng HT, Baker AJ, Hutchison MG, Churchill N, Inaba K, Nascimento BB, De Oliveira Manoel AL, Beckett A, Rhind SG (2016) Sympathoadrenal activation is associated with acute traumatic coagulopathy and endotheliopathy in isolated brain injury. Shock. 46:96–103. https://doi.org/10.1097/SHK.0000000000000642
Bender M, Stein M, Schoof B, Kolodziej MA, Uhl E, Schöller K (2020) Troponin I as an early biomarker of cardiopulmonary parameters during the first 24 h of intensive care unit treatment in isolated traumatic brain injury patients. Injury 51:1189–1195. https://doi.org/10.1016/j.injury.2020.01.002
Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, D’Avila TT, Souza DO, Portela LV, Stefani MA (2011) Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery. 68:1624–1631. https://doi.org/10.1227/NEU.0b013e318214a81f
Corrigan F, Arulsamy A, Teng J, Collins-Praino LE (2017) Pumping the brakes: neurotrophic factors for the prevention of cognitive impairment and dementia after traumatic brain injury. J Neurotrauma 34:971–986. https://doi.org/10.1089/neu.2016.4589
Dash PK, Zhao J, Hergenroeder G, Moore AN (2010) Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurother 7(1):100–14. https://doi.org/10.1016/j.nurt.2009.10.019
El-Menyar A, Goyal A, Latifi R, Al-Thani H, Frishman W (2017) Brain-heart interactions in traumatic brain injury. Cardiol Rev 25:279–288. https://doi.org/10.1097/CRD.0000000000000167
et al. C, (2016) 乳鼠心肌提取 HHS Public Access. Physiol Behav 176:139–148. https://doi.org/10.1016/j.physbeh.2017.03.040
Harhangi BS, Kompanje EJO, Leebeek FWG, Maas AIR (2008) Coagulation disorders after traumatic brain injury. Acta Neurochir 150:165–175
Harper MM, Rudd D, Meyer KJ, Kanthasamy AG, Anantharam V, Pieper AA, Vázquez-Rosa E, Shin M-K, Chaubey K, Koh Y, Evans LP, Bassuk AG, Anderson MG, Dutca L, Kudva IT, John M (2020) Identification of chronic brain protein changes and protein targets of serum auto-antibodies after blast-mediated traumatic brain injury. Heliyon 6:e03374. https://doi.org/10.1016/j.heliyon.2020.e03374
Hinson HE, Rowell S, Schreiber M (2015) Clinical evidence of inflammation driving secondary brain injury: a systematic review. J Trauma Acute Care Surg 78(1):184–191. https://doi.org/10.1097/TA.0000000000000468
Kirchhoff C, Stegmaier J, Bogner V, Buhmann S, Mussack T, Kreimeier U, Mutschler W, Biberthaler P (2006) Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J Neurotrauma 23:943–949. https://doi.org/10.1089/neu.2006.23.943
Kleindienst A, Brabant G, Morgenthaler NG, Dixit KC, Parsch H, Buchfelder M (2009) Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity. Acta Neurochir Suppl 106:221–4. https://doi.org/10.1007/978-3-211-98811-4_41
Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, Bragge P, Brazinova A, Büki A, Chesnut RM, Citerio G, Coburn M, Cooper DJ, Crowder AT, Czeiter E, Czosnyka M, Diaz-Arrastia R, Dreier JP, Duhaime A-C, Ercole A, van Essen TA, Feigin VL, Gao G, Giacino J, Gonzalez-Lara LE, Gruen RL, Gupta D, Hartings JA, Hill S, Jiang J, Ketharanathan N, Kompanje EJO, Lanyon L, Laureys S, Lecky F, Levin H, Lingsma HF, Maegele M, Majdan M, Manley G, Marsteller J, Mascia L, McFadyen C, Mondello S, Newcombe V, Palotie A, Parizel PM, Peul W, Piercy J, Polinder S, Puybasset L, Rasmussen TE, Rossaint R, Smielewski P, Söderberg J, Stanworth SJ, Stein MB, von Steinbüchel N, Stewart W, Steyerberg EW, Stocchetti N, Synnot A, Te Ao B, Tenovuo O, Theadom A, Tibboel D, Videtta W, Wang KKW, Williams WH, Wilson L, Yaffe K, Adams H, Agnoletti V, Allanson J, Amrein K, Andaluz N, Anke A, Antoni A, van As AB, Audibert G, Azaševac A, Azouvi P, Azzolini ML, Baciu C, Badenes R, Barlow KM, Bartels R, Bauerfeind U, Beauchamp M, Beer D, Beer R, Belda FJ, Bellander B-M, Bellier R, Benali H, Benard T, Beqiri V, Beretta L, Bernard F, Bertolini G, Bilotta F, Blaabjerg M, den Boogert H, Boutis K, Bouzat P, Brooks B, Brorsson C, Bullinger M, Burns E, Calappi E, Cameron P, Carise E, Castaño-León AM, Causin F, Chevallard G, Chieregato A, Christie B, Cnossen M, Coles J, Collett J, Della Corte F, Craig W, Csato G, Csomos A, Curry N, Dahyot-Fizelier C, Dawes H, DeMatteo C, Depreitere B, Dewey D, van Dijck J, Đilvesi Đ, Dippel D, Dizdarevic K, Donoghue E, Duek O, Dulière G-L, Dzeko A, Eapen G, Emery CA, English S, Esser P, Ezer E, Fabricius M, Feng J, Fergusson D, Figaji A, Fleming J, Foks K, Francony G, Freedman S, Freo U, Frisvold SK, Gagnon I, Galanaud D, Gantner D, Giraud B, Glocker B, Golubovic J, Gómez López PA, Gordon WA, Gradisek P, Gravel J, Griesdale D, Grossi F, Haagsma JA, Håberg AK, Haitsma I, Van Hecke W, Helbok R, Helseth E, van Heugten C, Hoedemaekers C, Höfer S, Horton L, Hui J, Huijben JA, Hutchinson PJ, Jacobs B, van der Jagt M, Jankowski S, Janssens K, Jelaca B, Jones KM, Kamnitsas K, Kaps R, Karan M, Katila A, Kaukonen K-M, De Keyser V, Kivisaari R, Kolias AG, Kolumbán B, Kolundžija K, Kondziella D, Koskinen L-O, Kovács N, Kramer A, Kutsogiannis D, Kyprianou T, Lagares A, Lamontagne F, Latini R, Lauzier F, Lazar I, Ledig C, Lefering R, Legrand V, Levi L, Lightfoot R, Lozano A, MacDonald S, Major S, Manara A, Manhes P, Maréchal H, Martino C, Masala A, Masson S, Mattern J, McFadyen B, McMahon C, Meade M, Melegh B, Menovsky T, Moore L, Morgado Correia M, Morganti-Kossmann MC, Muehlan H, Mukherjee P, Murray L, van der Naalt J, Negru A, Nelson D, Nieboer D, Noirhomme Q, Nyirádi J, Oddo M, Okonkwo DO, Oldenbeuving AW, Ortolano F, Osmond M, Payen J-F, Perlbarg V, Persona P, Pichon N, Piippo-Karjalainen A, Pili-Floury S, Pirinen M, Ple H, Poca MA, Posti J, Van Praag D, Ptito A, Radoi A, Ragauskas A, Raj R, Real RGL, Reed N, Rhodes J, Robertson C, Rocka S, Røe C, Røise O, Roks G, Rosand J, Rosenfeld JV, Rosenlund C, Rosenthal G, Rossi S, Rueckert D, de Ruiter GCW, Sacchi M, Sahakian BJ, Sahuquillo J, Sakowitz O, Salvato G, Sánchez-Porras R, Sándor J, Sangha G, Schäfer N, Schmidt S, Schneider KJ, Schnyer D, Schöhl H, Schoonman GG, Schou RF, Sir Ö, Skandsen T, Smeets D, Sorinola A, Stamatakis E, Stevanovic A, Stevens RD, Sundström N, Taccone FS, Takala R, Tanskanen P, Taylor MS, Telgmann R, Temkin N, Teodorani G, Thomas M, Tolias CM, Trapani T, Turgeon A, Vajkoczy P, Valadka AB, Valeinis E, Vallance S, Vámos Z, Vargiolu A, Vega E, Verheyden J, Vik A, Vilcinis R, Vleggeert-Lankamp C, Vogt L, Volovici V, Voormolen DC, Vulekovic P, Vande Vyvere T, Van Waesberghe J, Wessels L, Wildschut E, Williams G, Winkler MKL, Wolf S, Wood G, Xirouchaki N, Younsi A, Zaaroor M, Zelinkova V, Zemek R, Zumbo F (2017) Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol 16:987–1048. https://doi.org/10.1016/S1474-4422(17)30371-X
Mahan MY, Thorpe M, Ahmadi A, Abdallah T, Casey H, Sturtevant D, Judge-Yoakam S, Hoover C, Rafter D, Miner J, Richardson C, Samadani U (2019) Glial fibrillary acidic protein (GFAP) outperforms S100 calcium-binding protein B (S100B) and ubiquitin C-terminal hydrolase L1 (UCH-L1) as predictor for positive computed tomography of the head in trauma subjects. World Neurosurg 128:e434–e444. https://doi.org/10.1016/j.wneu.2019.04.170
Papa L, Robicsek SA, Brophy GM, Wang KKW, Hannay HJ, Heaton S, Schmalfuss I, Gabrielli A, Hayes RL, Robertson CS (2018) Temporal profile of microtubule-associated protein 2: a novel indicator of diffuse brain injury severity and early mortality after brain trauma. J Neurotrauma 35:32–40. https://doi.org/10.1089/neu.2017.4994
Rahmani F (2016) Diagnostic value of brain natriuretic peptide in head trauma. J Anal Res Clin Med 4:75–76. https://doi.org/10.15171/jarcm.2016.012
Ramezani F, Bahrami-Amiri A, Babahajian A, Shahsavari Nia K, Yousefifard M (2018) Ubiquitin C-terminal hydrolase-L1 (UCH-L1) in prediction of computed tomography findings in traumatic brain injury; a meta-analysis. Emerg (Tehran) 6:e62
Regner A, Meirelles L d S, Ikuta N, Cecchini A, Simon D (2018) Prognostic utility of circulating nucleic acids in acute brain injuries. Expert Rev Mol Diagn 18:925–938. https://doi.org/10.1080/14737159.2018.1535904
Rubenstein R, Chang B, Davies P, Wagner AK, Robertson CS, Wang KKW (2015) A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids. J Neurotrauma 32:342–352. https://doi.org/10.1089/neu.2014.3548
Rubenstein R, Chang B, Yue JK, Chiu A, Winkler EA, Puccio AM, Diaz-Arrastia R, Yuh EL, Mukherjee P, Valadka AB, Gordon WA, Okonkwo DO, Davies P, Agarwal S, Lin F, Sarkis G, Yadikar H, Yang Z, Manley GT, Wang KKW, Cooper SR, Dams-O’Connor K, Borrasso AJ, Inoue T, Maas AIR, Menon DK, Schnyer DM, Vassar MJ (2017) Comparing plasma phospho tau, total tau, and phospho tau–total tau ratio as acute and chronic traumatic brain injury biomarkers. JAMA Neurol 74:1063–1072. https://doi.org/10.1001/jamaneurol.2017.0655
Sandmo SB, Filipcik P, Cente M, Hanes J, Andersen TE, Straume-Naesheim TM, Bahr R (2020) Neurofilament light and tau in serum after head-impact exposure in soccer. Brain Inj 34:602–609. https://doi.org/10.1080/02699052.2020.1725129
Siman R, Cui H, Wewerka SS, Hamel L, Smith DH, Zwank MD (2020) Serum SNTF, a Surrogate marker of axonal injury, is prognostic for lasting brain dysfunction in mild TBI treated in the emergency department. Front Neurol 11. https://doi.org/10.3389/fneur.2020.00249
Stein SC, Smith DH (2004) Coagulopathy in traumatic brain injury. Neurocrit Care 1:479–488
Sviri GE, Soustiel JF, Zaaroor M (2006) Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir 148:529–533. https://doi.org/10.1007/s00701-005-0666-4
Taylor CA, Bell JM, Breiding MJ, Xu L (2017) Traumatic brain injury-related emergency department visits, hospitalizations, and deaths - United States, 2007 and 2013. MMWR Surveill Summ. https://doi.org/10.15585/mmwr.ss6609a1
Thelin E, Al Nimer F, Frostell A, Zetterberg H, Blennow K, Nyström H, Svensson M, Bellander BM, Piehl F, Nelson DW (2019) A Serum protein biomarker panel improves outcome prediction in human traumatic brain injury. J Neurotrauma 36:2850–2862. https://doi.org/10.1089/neu.2019.6375
Tu CF, Su YH, Huang YN, Tsai MT, Li LT, Chen YL, Cheng CJ, Dai DF, Yang RB (2006) Localization and characterization of a novel secreted protein SCUBE1 in human platelets. Cardiovasc Res 71:486–495. https://doi.org/10.1016/j.cardiores.2006.04.010
Wagner AK, Zitelli KT (2013) A Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiology. 20:39–48. https://doi.org/10.1016/j.pathophys.2012.02.007
Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT (2018) An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn 18:165–180
Winston CN, Romero HK, Ellisman M, Nauss S, Julovich DA, Conger T, Hall JR, Campana W, O’Bryant SE, Nievergelt CM, Baker DG, Risbrough VB, Rissman RA (2019) Assessing neuronal and astrocyte derived exosomes from individuals with mild traumatic brain injury for markers of neurodegeneration and cytotoxic activity. Front Neurosci 13. https://doi.org/10.3389/fnins.2019.01005
Wu X, Sha H, Sun Y, Gao L, Liu H, Yuan Q, Zhang T, Zhu J, Zhou L, Hu J (2011) N-terminal pro-B-type natriuretic peptide in patients with isolated traumatic brain injury: a prospective cohort study. J Trauma 71:820–825. https://doi.org/10.1097/TA.0b013e3182277b69
Wurzelmann M, Romeika J, Sun D (2017) Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury. Neural Regen Res 12:7. https://doi.org/10.4103/1673-5374.198964
Yue JK, Upadhyayula PS, Avalos LN, Deng H, Wang KKW (2020) The role of blood biomarkers for magnetic resonance imaging diagnosis of traumatic brain injury. Medicina (Kaunas) 56:87. https://doi.org/10.3390/medicina56020087
Zhang Y, Feng Z, Bao Y, Zhou L, Qiu B (2017) Could B-type natriuretic peptides be a biomarker for trauma brain injury? A systematic review and meta-analysis. Am J Emerg Med 35:1695–1701. https://doi.org/10.1016/j.ajem.2017.05.051
Zhang Z-Y, Li J, Ye Q, Dong Y, Bao G-M, Shen Y-K, Weng J-F, Luo L-F, Cen M (2019) Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury. Clin Chim Acta 497:6–12. https://doi.org/10.1016/j.cca.2019.07.008
Zhou HJ, Zhang HN, Tang T, Zhong JH, Qi Y, Luo JK, Lin Y, Yang QD, Li XQ (2010) Alteration of thrombospondin-1 and -2 in rat brains following experimental intracerebral hemorrhage: Laboratory investigation. J Neurosurg 113:820–825. https://doi.org/10.3171/2010.1.JNS09637
Funding
This work had support from the CNPq, Conselho Nacional de Desenvolvimento Científico e Tecnológico- Brazil.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The local IRB waived the need for ethical approval due to the retrospective nature of the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gutierre, M.U., Telles, J.P.M., Welling, L.C. et al. Biomarkers for traumatic brain injury: a short review. Neurosurg Rev 44, 2091–2097 (2021). https://doi.org/10.1007/s10143-020-01421-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-020-01421-0